(Q33973013)

English

Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tr

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tr (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

pharmacotherapy

0 references

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

Justin Ezekowitz

object named as

Justin Ezekowitz

5

0 references

author name string

Edith Pituskin

1

1 reference

Europe PubMed Central

30 July 2017

Mark Haykowsky

2

1 reference

Europe PubMed Central

30 July 2017

John R Mackey

3

1 reference

Europe PubMed Central

30 July 2017

Richard B Thompson

4

1 reference

Europe PubMed Central

30 July 2017

Sheri Koshman

6

1 reference

Europe PubMed Central

30 July 2017

Gavin Oudit

7

1 reference

Europe PubMed Central

30 July 2017

Kelvin Chow

8

1 reference

Europe PubMed Central

30 July 2017

Joseph J Pagano

9

1 reference

Europe PubMed Central

30 July 2017

Ian Paterson

10

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

27 July 2011

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

11

1 reference

Europe PubMed Central

30 July 2017

318

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-318

0 references

Role of biomarkers in chemotherapy-induced cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Biomarkers in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Genomics in cardiac metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Early breast cancer therapy and cardiovascular injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

A systematic review: effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Mechanisms and models in heart failure: the biomechanical model and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

The tumor metabolome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Circulating biomarkers of collagen metabolism in cardiac diseases

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnetic resonance imaging in cardiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Troponin I and cardiovascular risk stratification in patients with testicular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity of trastuzumab in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-318

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33973013&oldid=1639614055"